New information and research about minor cannabinoids – among the 100-200 that have been identified – is helping treat different health and wellness conditions and allowing cannabis companies to sell a wider variety of products.
When New York regulators announced plans to double recreational marijuana retail licenses to 300 for social equity applicants, local cannabis operators and other industry advocates applauded the news.
But behind the scenes, concerns were mounting over the challenge of finding affordable cannabis real estate across large parts of the state because of zoning and commercial restrictions.
Cannabis companies have begun advertising on Twitter for the first time, but so far the results have been mixed.
Marijuana multistate operator TerrAscend Corp. could become the first U.S. plant-touching company to list on the Toronto Stock Exchange by this summer if the restructuring plan it shared with shareholders and analysts wins TSX approval.
Canada-based Adastra Holdings faces a proposed class action lawsuit from a shareholder who alleges the cannabis company made “misleading statements about (its) ability to legally sell cocaine.”
Potency testing on store-bought cannabis flower by a Canadian laboratory has found THC levels significantly lower than the labeled value, sparking an industrywide conversation about how to address inaccurate THC claims.
In an industry that once had an unusually high percentage of female CEOs, the marijuana sector now has fewer women in leadership positions than the U.S. average.
